Proteogenomics of colorectal cancer liver metastases: complementing precision oncology with phenotypic data

HIGHLIGHTS

• who: KRAS and collaborators from the Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Bochum, Germany have published the research work: Proteogenomics of Colorectal Cancer Liver Metastases: Complementing Precision Oncology with Phenotypic Data, in the Journal: (JOURNAL) of 15/09/2017
• what: The authors demonstrate how targeted mass (Clinicaltrials.gov NCT00984048). Given the energy a cell has to invest in producing a functional protein, the authors propose that over-expressed proteins represent molecules that give the tumor cells a growth advantage. Although this indicates a minimum impact of sampling-derived . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.